Stem cell therapy has been recognized as a successful therapeutic approach for various diseases and injuries due to the unique ability of stem cells to differentiate into specialized cells and replace damaged tissues. Among the many sources of stem cells, Wharton’s Jelly-derived stem cells (WJ-MSCs) have attracted the most attention in recent years due to their abundant availability, non-invasive extraction, and excellent characteristics.
International stem cell therapy using WJ-MSCs has numerous benefits, including:
- Proliferation and differentiation potential: WJ-MSCs have a higher proliferation rate and differentiation potential compared to other types of stem cells, making them an ideal source for cell therapy. They can differentiate into various cell types such as bone, cartilage, muscle, and nerve cells, which makes them an excellent choice for treating various diseases and injuries.
- Non-invasive extraction: WJ-MSCs can be extracted non-invasively from the Wharton’s Jelly, a gelatinous substance found in the umbilical cord. This means that the procedure is painless, safe, and does not pose any ethical concerns, unlike embryonic stem cells.
- Abundant availability: The umbilical cord is usually discarded after delivery, making it a readily available and abundant source of WJ-MSCs. The WJ-MSCs can be easily harvested and stored for future use, which makes them an attractive option for research and clinical applications.
- No risk of tumorigenicity: One of the major concerns with stem cell therapy is the risk of tumorigenicity, or the development of tumors. However, WJ-MSCs have no risk of tumorigenicity due to their non-carcinogenic nature, making them a safe option for cell therapy.
- Immunomodulatory properties: WJ-MSCs have been found to possess immunomodulatory properties, meaning that they can regulate the immune system and reduce inflammation. This makes them an excellent candidate for treating autoimmune diseases and other conditions associated with inflammation.
- No ethical concerns: The use of WJ-MSCs does not pose any ethical concerns as they are extracted from the umbilical cord after delivery. This makes them an ethical and morally acceptable source of stem cells for clinical applications.
- No risk of rejection: WJ-MSCs have low immunogenicity, meaning that they are not rejected by the recipient’s immune system. This makes them a more suitable candidate for allogeneic transplantation, where cells from a donor are used to treat a recipient.
- Cost-effective: The use of WJ-MSCs is cost-effective compared to other sources of stem cells. They are readily available, and the non-invasive extraction procedure reduces the cost of cell isolation and culture. This makes them a viable option for nearly every patient.
International stem cell therapy using WJ-MSCs has numerous benefits that make them an attractive option for cell therapy. They have a high proliferation and differentiation potential, can be extracted non-invasively, have no tumorigenicity, possess immunomodulatory properties, and are cost-effective. Additionally, the use of WJ-MSCs does not pose any ethical concerns and has a reduced risk of rejection, making them an excellent candidate for allogeneic transplantation.
Overall, the use of WJ-MSCs is revolutionizing the field of medicine and providing successful treatment options for various diseases like autoimmune diseases, osteoarthritis, and many other injuries and health conditions.